These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38482176)

  • 101. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
    Boehner A; Navarini AA; Eyerich K
    Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study.
    Hayama K; Iwasaki R; Tian Y; Fujita H
    J Dermatol; 2023 Dec; 50(12):1531-1538. PubMed ID: 37721393
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study.
    Imafuku S; Honma M; Okubo Y; Komine M; Ohtsuki M; Morita A; Seko N; Kawashima N; Ito S; Shima T; Nakagawa H
    J Dermatol; 2016 Sep; 43(9):1011-7. PubMed ID: 26919410
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Clinical analysis of 82 cases of generalized pustular psoriasis].
    Wu X; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):173-178. PubMed ID: 28255119
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Secukinumab for the treatment of generalized pustular psoriasis: A case report.
    Li J; Gao X; Ma L; Fang Y
    Medicine (Baltimore); 2023 May; 102(18):e33693. PubMed ID: 37144985
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Loss of Function
    Kantaputra P; Daroontum T; Chuamanochan M; Chaowattanapanit S; Intachai W; Olsen B; Sastraruji T; Tongsima S; Ngamphiw C; Kampuansai J; Cox TC; Kiratikanon S
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672844
    [TBL] [Abstract][Full Text] [Related]  

  • 107. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination.
    Narang T; Sharma A; Bhandari A; Handa S; Dogra S
    Indian J Dermatol; 2023; 68(6):726. PubMed ID: 38371580
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity.
    Samotij D; Szczęch J; Reich A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445754
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Successful treatment of generalized pustular psoriasis with guselkumab.
    Part M
    J Dermatolog Treat; 2024 Dec; 35(1):2331807. PubMed ID: 38522861
    [No Abstract]   [Full Text] [Related]  

  • 110. Generalized Pustular Psoriasis and Systemic Organ Dysfunctions.
    Teshima R; Saito-Sasaki N; Sawada Y
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892457
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
    Frysz M; Patel S; Li MOY; Griffiths CEM; Warren RB; Ashcroft DM
    Br J Dermatol; 2024 May; ():. PubMed ID: 38775029
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis.
    Teshima R; Saito-Sasaki N; Hitaka T; Sawada Y
    Cureus; 2024 May; 16(5):e60331. PubMed ID: 38883056
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
    Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; de Francisco JMS; Daudén Tello E
    Actas Dermosifiliogr; 2024 Jul; ():. PubMed ID: 38972580
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
    Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; Soria de Francisco JM; Daudén Tello E
    Actas Dermosifiliogr; 2024 May; ():. PubMed ID: 38777227
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Development of the Generalized Pustular Psoriasis Clinical Assessment Tool.
    Garg A; Noe MH; Anadkat MJ; Armstrong A; Bhutani T; Farberg A; Han G; Hawkes JE; Lebwohl M; Rekhtman S; Song EJ; Strunk A; Duffin KC
    J Am Acad Dermatol; 2024 Jan; 90(1):192-195. PubMed ID: 37739266
    [No Abstract]   [Full Text] [Related]  

  • 116. Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.
    Barker JN; Becher G; Burden DA; Pink AE; Zacharioudaki M; Warren RB
    Skin Health Dis; 2024 Jun; 4(3):e359. PubMed ID: 38846692
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
    Suzuki S; Kamata M; Ito M; Watanabe A; Uchida H; Chijiwa C; Azuma S; Hayashi K; Sugiura K; Tada Y
    J Dermatol; 2024 Jun; ():. PubMed ID: 38874489
    [No Abstract]   [Full Text] [Related]  

  • 118. Generalized pustular psoriasis successfully treated with spesolimab in the setting of metastatic colon cancer.
    Guy DR; DeVore S; Kirtani V; Duffy N
    JAAD Case Rep; 2024 Aug; 50():6-8. PubMed ID: 39036611
    [No Abstract]   [Full Text] [Related]  

  • 119. A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
    Minami Y; Shinkuma S; Yokoyama T; Shinoda S; Hamada K; Arima A; Ogawa K; Miyagawa F; Asada H
    J Dermatol; 2024 Apr; ():. PubMed ID: 38680031
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.